New York City, NY -- (SBWIRE) -- 10/29/2013 -- StockMarketIntel.com issues a special report on the following stocks: Federal Home Loan Mortgage Corp (OTCBB:FMCC), Microsoft Corporation (NASDAQ:MSFT), Myriad Genetics, Inc. (NASDAQ:MYGN), Catalyst Pharmaceutical Partners, Inc. (NASDAQ:CPRX)
Federal Home Loan Mortgage Corp (OTCBB:FMCC) added 11.59% trading on 19.13 million shares, to end the trade at $2.31. If we look at its trading history of the past 52 weeks, the share price suffered a low of $0.26 and was moved to the maximum level of $5.00. The stock changed hands in a range of $2.16 to $2.31, bringing its market capitalization to about $1.50 billion. Federal Home Loan Mortgage Corporation (Freddie Mac) conducts business in the United States residential mortgage market and the global securities market. The Company operates in three segments: Single-family Guarantee, Investments, and Multifamily. The Single-family Guarantee segment reflects results from the Company's single-family credit guarantee activities. The Investments segment reflects results from the Company's investment, funding and hedging activities.
Why Should Investors Buy FMCC After The Recent Gain? Just Go Here and Find Out
Microsoft Corporation (NASDAQ:MSFT) declined -0.54%, to complete the trading session at $35.57, with a total volume of 38.23 million shares. The stock, on average, trades on a volume of 46.62 million shares. In the past 52 weeks, the share price has not declined below $26.26 and above $36.43. It floated in a range of $35.27 to $35.73 during the last trading session, with a beta value of 0.96. Its market capitalization now moved to about $296.94 billion. Microsoft Corporation is engaged in developing, licensing and supporting a range of software products and services. The Company operates in five segments: Windows & Windows Live Division (Windows Division), Server and Tools, Online Services Division (OSD), Microsoft Business Division (MBD), and Entertainment and Devices Division (EDD). The Company’s products include operating systems for personal computers (PCs), servers, phones, and other intelligent devices; server applications for distributed computing environments; productivity applications; business solution applications; desktop and server management tools; software development tools; video games, and online advertising.
Has MSFT Found The Bottom and Ready To Move Up? Find Out Here
Myriad Genetics, Inc. (NASDAQ:MYGN) recorded a gain of 1.38% and was in a range of $25.31-$26.16 before closing at $25.66. The share price hit its 52-week low of $22.20 and $38.27 was the best price. The stock completed the day with a total volume of 1.43 million shares, versus an average volume of 2.70 million shares. Myriad Genetics, Inc. (Myriad) is a molecular diagnostic company. The Company is focused on developing and marketing predictive medicine, personalized medicine and prognostic medicine tests. It performs all of its molecular diagnostic testing and analysis in its own reference laboratories.
What was the Moving Force behind MYGN on Bullish Run? Read This Research Report
Catalyst Pharmaceutical Partners, Inc. (NASDAQ:CPRX) declined -2.67%, bringing its market capitalization around $96.27 million. The total number of shares that changed hands during the session was 1.03 million shares, as compared to average trading volume of 2.78 million shares. The share price, after opening at $1.91, made a high of $1.96 and hovered above $1.82 to end the day at $1.82. Catalyst Pharmaceutical Partners, Inc. is a development-stage biopharmaceutical company. The Company is focused on the development and commercialization of prescription drugs targeting addiction diseases and disorders of the central nervous system with a focus on the treatment of addiction and epilepsy.
Has CPRX Found The Bottom And Ready To Gain Momentum? Find Out Here
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list.
Neither StockMarketIntel.com, nor its employees and affiliates are registered as investment advisors or broker/dealers in any jurisdiction whatsoever. Through use of this website viewing or using you agree to hold StockMarketIntel.com, its operators, owners, employees, and affiliates harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Readers should always do their own due diligence and consult a financial professional. StockMarketIntel.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and StockMarketIntel.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled company. Any opinions expressed on this website are statements of judgment as of the date of publication and are subject to change without further notice, and may not necessarily be reprinted in future publications or elsewhere.
Read Full disclaimer at: http://stockmarketintel.com/Disclaimer.htm
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)